Tumor necrosis factor alpha gene polymorphism is associated with cerebral infarction

Molecular Brain Research

Volumn 122, Issue 1, 2004, Pages 99-102

  Um, Jae Young ^a   Kim, Hyung Min ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Cerebral infarction; Disorders of the nervous system; Ischemia; Polymorphism; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE LOCATION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE;

EID: 1342328026     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2003.11.019     Document Type: Article

References (31)

1. Andreotti F., Porto I., Crea F., Maseri A. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart. 87:2002;107-112.
2. Barone F.C., Arvin B., White R.F., Miller A., Webb C.L., Willette R.N., Lysko P.G., Feuerstein G.Z. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke. 28:1997;1233-1244.
3. Braun N., Michel U., Ernst B.P., Metzner R., Bitsch A., Weber F., Rieckmann P. Gene polymorphism at position -308 of the tumor-necrosis-factor- alpha (TNF-alpha) in multiple sclerosis and its influence on the regulation of TNF-alpha production. Neurosci. Lett. 215:1996;75-78.
4. Bruce A.J., Boling W., Kindy M.S., Peschon J., Kraemer P.J., Carpenter M.K., Holtsberg F.W., Mattson M.P. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nat. Med. 2:1996;788-794.
5. Cabrera M., Shaw M.A., Sharples C., Williams H., Castes M., Convit J., Blackwell J.M. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182:1995;1259-1264.
6. Cheng B., Christakos S., Mattson M.P. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron. 14:1994;139-153.
7. Clark W.M. Cytokines and reperfusion injury. Neurology. 49:1997;S10-S14.
8. Collier P.M., Wojnarowska F., McGuire B., Welsh K.I. Polymorphism of tumor necrosis factor a promoter region of the MHC is strongly associated with linear IgA disease and affects prognosis. Br. J. Dermatol. 131:1994;22.
9. Dawson D.A., Martin D., Hallenbeck J.M. Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neurosci. Lett. 218:1996;41-44.
10. Elneihoum A.M., Falke P., Hedblad B., Lindgarde F., Ohlsson K. Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis. 131:1997;79-84.
11. Gary D.S., Bruce-Keller A.J., Kindy M.S., Mattson M.P. Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor. J. Cereb. Blood Flow Metab. 18:1998;1283-1287.
12. Lavine S.D., Hofman F.M., Zlokovic B.V. Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury. J. Cereb. Blood Flow Metab. 18:1998;52-58.
13. McGuire W., Hill A.V., Allsopp C.E.M., Greenwood B.M., Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 371:1994;508-510.
14. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215.
15. Nawashiro H., Martin D., Hallenbeck J.M. Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res. 778:1997;265-271.
16. Nawashiro H., Martin D., Hallenbeck J.M. Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. J. Cereb. Blood Flow Metab. 17:1997;229-232.
17. Nawashiro H., Tasaki K., Ruetzler C.A., Hallenbeck J.M. TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 17:1997;483-490.
18. Paleolog E.M., Delasalle S.A., Buurman W.A., Feldmann M. Functional activities of receptors for tumor necrosis factor-alpha on human vascular endothelial cells. Blood. 84:1994;2578-2590.
19. Ross R. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
20. Scherbel U., Raghupathi R., Nakamura M., Saatman K.E., Trojanowski J.Q., Neugebauer E., Marino M.W., McIntosh T.K. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 96:1999;8721-8726.
21. Shohami E., Bass R., Wallach D., Yamin A., Gallily R. Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 16:1996;378-384.
22. Shohami E., Ginis I., Hallenbeck J.M. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 10:1999;119-130.
23. Stoll G., Jander S., Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog. Neurobiol. 56:1998;149-171.
24. Toborek M., Blanc E.M., Kaiser S., Mattson M.P., Hennig B. Linoleic acid potentiates TNF-mediated oxidative stress, disruption of calcium homeostasis, and apoptosis of cultured vascular endothelial cells. J. Lipid. Res. 38:1997;2155-2167.
25. Um J.Y., Moon K.S., Lee K.M., Yun J.M., Cho K.H., Moon B.S., Kim H.M. Association of interleukin-1 alpha gene polymorphism with cerebral infarction. Mol. Brain Res. 115:2003;50-54.
26. Wilson A.G., Clay F.E., Crane A.M., Cork M.J., Duff G.W. Genetics of tumor necrosis factor alpha in dermatitis herpetiformis. J. Invest. Dermatol. 104:1995;856-858.
27. Wilson A.G., DiGiovine F.S., Duff G.W. Genetics of tumor necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J. Inflamm. 45:1995;1-12.
28. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. U. S. A. 94:1997;3195-3199.
29. Woods A., Brull D.J., Humphries S.E., Montgomery H.E. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur. Heart J. 21:2000;1574-1583.
30. Wu W.S., McClain K.L. DNA polymorphisms and mutation of the tumor necrosis-alpha (TNF-alpha) promoter in Langerhans cell histiocytosis (LCH). J. Interferon Cytokine Res. 17:1997;631-635.
31. Yoshizumi M., Perrella M.A., Burnett J.C. Jr., Lee M.E. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ. Res. 73:1993;205-209.